The characters shown are real patients and the required consent to use their stories has been obtained from the patients and families. Photographs are for illustrative purposes only.
The natural history for patients with SMA is a progressive loss of motor function, often including ambulation, regardless of age and disease subtype.1
Head of the Neuromuscular Reference Centre, Paediatrics and Child Neurology, University Hospitals Leuven.
Watch video nowvideoWrapper1
Chief Senior Physician, Clinic of Neurology, Essen University Hospital.
Watch video nowvideoWrapperReversed1
Loss of motor function can impact a patient’s ability to perform daily routine tasks and, as a result, their independence.
Learn more about the disease
Proactive care by both clinicians and family are of paramount importance.3
Stabilisation of motor function is an important goal for adults living with SMA.3
In a European survey, 81% of patients and their caregivers reported disease stabilisation would represent major progress.3 With improved and emerging standards of care, increasing numbers of SMA patients will reach adulthood.
Director of the Clinic for Neurology, Essen University Hospital
Watch video nowvideoWrapperReversed3
In a European patient survey 822 patients with SMA type II and III and their caregivers were asked which motor function they would wish to preserve.3
Can you guess which motor function was prioritized by 37% of respondents?
a. Wash independently
b. Using a keyboard
c. Self-feeding
Learn more about what matters to people living with later onset SMA and how you can support them in preserving their independence.
Tel Aviv Sourasky Medical Center
Watch video nowvideoWrapper3
When it comes to objective measures for SMA in adult patients, Dr Vivian Drory noted that:“We do not have good measures for adult patients” [and] “We do not have measures for very small changes”
Measuring scales reflect relatively large changes, but small changes are important for patients in their daily life. In practice, patient-reported improvements need to be taken into consideration when assessing function. Dr Vivian Drory said, “They can do some tasks easier than before – but it is not something that we can measure readily.”
NEuroMuscular Omnicentre, Milan
Watch video nowvideoWrapperReversed2
“[We] know how much a discrepancy there is between the muscle strength and the muscle function and what the perceptions the patients have”
When asked about function that is meaningful to patients, it was found that these are not always reflected in the traditional scales. Dr. Valeria Sansone said, “if you need to move from a zero to a 1 or a 2 – it is a big function that has to change”.
In addition, the differences between timepoints may not reflect the real benefit, requiring the need to work on these outcome measures to capture these changes.
Dr. Valeria Sansone speaks how patients' perceptions can be measured and elaborates on a semistructured qualitative interview with patients and their primary caregivers. Dr. Valeria Sansone said, “We are trying to match the perceptions of the patients and caregivers to what the real scales are saying.”
Learn more about Biogen's offering for:
The characters shown are real patients and the required consent to use their stories has been obtained from the patients and families. Photographs are for illustrative purposes only.
1. Kaufmann P, et al. Prospective cohort study of spinal muscular atrophy types 2 and 3. Neurol 2012;79:1889-1897.
2. Swoboda KJ, et al. Perspectives on clinical trials in spinal muscular atrophy. J Child Neurol 2007;22(8):957-966.
3. Rouault F, et al. Disease impact on general well-being and therapeutic expectations of European Type II and Type III spinal muscular atrophy patients. Neuromuscul Disord 2017;27(5):428-438.
4. Wadman RI, Wijngaarde CA, Stam M, et al. Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with SMA types 1c-4. Eur J Neurol 2018;25(3):512-518.